Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value

$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck research and Development (R&D) ($M) ($M)

Postgres DB financial_values

Quarterly Annual

Latest, Q2 2026

9,741

Period ended Jun 30, 2026

Change on a year earlier

+140.6%

4,048 in Q2 2025

History

69 quarters

Since Q2 2008

Sources

Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

Period	Ended	Research and Development (R&D) ($M) ($M)	Year on year	Source
Q2 2026	Jun 30, 2026	9,741	+140.6%	Form 10-Q (filed 2026-08-07) ↗
Q1 2026	Mar 31, 2026	12,592	+247.7%	Form 10-Q (filed 2026-05-04) ↗
Q4 2025	Dec 31, 2025	3,886	-15.2%	Form 10-K (filed 2026-02-24) ↗
Q3 2025	Sep 30, 2025	4,234	-27.8%	Form 10-Q (filed 2025-11-05) ↗
Q2 2025	Jun 30, 2025	4,048	+15.7%	Form 10-Q (filed 2025-08-05) ↗
Q1 2025	Mar 31, 2025	3,621	-9.3%	Form 10-Q (filed 2025-05-02) ↗
Q4 2024	Dec 31, 2024	4,584	-52.4%	Form 10-K (filed 2025-02-25) ↗
Q3 2024	Sep 30, 2024	5,862	+77.3%	Form 10-Q (filed 2024-11-06) ↗
Q2 2024	Jun 30, 2024	3,500	-73.7%	Form 10-Q (filed 2024-08-05) ↗
Q1 2024	Mar 31, 2024	3,992	-6.6%	Form 10-Q (filed 2024-05-03) ↗
Q4 2023	Dec 31, 2023	9,627	+155.0%	Form 10-K (filed 2024-02-26) ↗
Q3 2023	Sep 30, 2023	3,307	-24.8%	Form 10-Q (filed 2023-11-03) ↗
Q2 2023	Jun 30, 2023	13,321	+376.1%	Form 10-Q (filed 2023-08-07) ↗
Q1 2023	Mar 31, 2023	4,276	+66.0%	Form 10-Q (filed 2023-05-05) ↗
Q4 2022	Dec 31, 2022	3,775	+23.0%	Form 10-K (filed 2023-02-24) ↗
Q3 2022	Sep 30, 2022	4,399	+79.9%	Form 10-Q (filed 2022-11-03) ↗
Q2 2022	Jun 30, 2022	2,798	-35.2%	Form 10-Q (filed 2022-08-05) ↗
Q1 2022	Mar 31, 2022	2,576	+6.8%	Form 10-Q (filed 2022-05-05) ↗
Q4 2021	Dec 31, 2021	3,068	-47.0%	Form 10-K (filed 2022-02-25) ↗
Q3 2021	Sep 30, 2021	2,445	-27.0%	Form 10-Q (filed 2021-11-05) ↗
Q2 2021	Jun 30, 2021	4,321	+107.2%	Form 10-Q (filed 2021-08-09) ↗
Q1 2021	Mar 31, 2021	2,412	+9.2%	Form 10-Q (filed 2022-05-05) ↗
Q4 2020	Dec 31, 2020	5,788	+141.2%	Form 10-K (filed 2022-02-25) ↗
Q3 2020	Sep 30, 2020	3,349	+4.5%	Form 10-Q (filed 2021-11-05) ↗
Q2 2020	Jun 30, 2020	2,085	-4.8%	Form 10-Q (filed 2021-08-09) ↗
Q1 2020	Mar 31, 2020	2,209	+14.4%	Form 10-Q (filed 2020-05-06) ↗
Q4 2019	Dec 31, 2019	2,400	+8.4%	Form 10-K (filed 2022-02-25) ↗
Q3 2019	Sep 30, 2019	3,204	+54.9%	Form 10-Q (filed 2019-11-05) ↗
Q2 2019	Jun 30, 2019	2,189	-3.7%	Form 10-Q (filed 2019-08-06) ↗
Q1 2019	Mar 31, 2019	1,931	-39.6%	Form 10-Q (filed 2019-05-08) ↗
Q4 2018	Dec 31, 2018	2,214	-4.4%	Form 10-K (filed 2019-02-27) ↗
Q3 2018	Sep 30, 2018	2,068	-53.1%	Form 10-Q (filed 2018-11-06) ↗
Q2 2018	Jun 30, 2018	2,274	+27.6%	Form 10-Q (filed 2018-08-07) ↗
Q1 2018	Mar 31, 2018	3,196	+74.6%	Form 10-Q (filed 2018-05-08) ↗
Q4 2017	Dec 31, 2017	2,315	-51.6%	Form 10-K (filed 2019-02-27) ↗
Q3 2017	Sep 30, 2017	4,413	+165.2%	Form 10-Q (filed 2018-11-06) ↗
Q2 2017	Jun 30, 2017	1,782	-17.2%	Form 10-Q (filed 2018-08-07) ↗
Q1 2017	Mar 31, 2017	1,830	+10.3%	Form 10-Q (filed 2018-05-08) ↗
Q4 2016	Dec 31, 2016	4,786	+166.2%	Form 10-K (filed 2019-02-27) ↗
Q3 2016	Sep 30, 2016	1,664	+10.9%	SEC Filing ↗
Q2 2016	Jun 30, 2016	2,151	+28.8%	SEC Filing ↗
Q1 2016	Mar 31, 2016	1,659	-4.5%	SEC Filing ↗
Q4 2015	Dec 31, 2015	1,798	-21.2%	Form 10-K (filed 2016-02-26) ↗
Q3 2015	Sep 30, 2015	1,500	-9.6%	Form 10-Q (filed 2015-11-05) ↗
Q2 2015	Jun 30, 2015	1,670	+0.4%	Form 10-Q (filed 2015-08-06) ↗
Q1 2015	Mar 31, 2015	1,737	+10.4%	Form 10-Q (filed 2015-05-07) ↗
Q4 2014	Dec 31, 2014	2,283	–	Form 10-K (filed 2015-02-27) ↗
Q3 2014	Sep 30, 2014	1,659	-55.9%	Form 10-Q (filed 2014-11-10) ↗
Q2 2014	Jun 30, 2014	1,664	–	Form 10-Q (filed 2014-08-07) ↗
Q1 2014	Mar 31, 2014	1,574	-17.5%	Form 10-Q (filed 2014-05-08) ↗
Q2 2013	Sep 30, 2013	3,761	+96.1%	Form 10-Q (filed 2013-11-07) ↗
Q1 2013	Mar 31, 2013	1,907	+2.4%	Form 10-Q (filed 2013-05-09) ↗
Q4 2012	Dec 31, 2012	2,224	-8.1%	Form 10-K (filed 2013-02-28) ↗
Q3 2012	Sep 30, 2012	1,918	-1.8%	Form 10-Q (filed 2012-11-09) ↗
Q2 2012	Jun 30, 2012	2,165	–	Form 10-Q (filed 2012-08-07) ↗
Q1 2012	Mar 31, 2012	1,862	–	Form 10-Q (filed 2012-05-08) ↗
Q4 2011	Dec 31, 2011	2,419	-46.9%	Form 10-K (filed 2012-02-28) ↗
Q3 2011	Sep 30, 2011	1,954	-15.8%	Form 10-Q (filed 2011-11-08) ↗
Q4 2010	Dec 31, 2010	4,559	+131.2%	Form 10-K (filed 2012-02-28) ↗
Q3 2010	Sep 30, 2010	2,322	+85.2%	Form 10-Q (filed 2011-11-08) ↗
Q2 2010	Jun 30, 2010	2,179	+56.2%	Form 10-Q (filed 2011-08-08) ↗
Q1 2010	Mar 31, 2010	2,051	+67.5%	Form 10-Q (filed 2011-05-09) ↗
Q4 2009	Dec 31, 2009	1,972	-7.3%	Form 10-Q (filed 2010-11-08) ↗
Q3 2009	Sep 30, 2009	1,254	+40.4%	Form 10-Q (filed 2010-11-08) ↗
Q2 2009	Jun 30, 2009	1,395	+54.0%	Form 10-Q (filed 2010-08-06) ↗
Q1 2009	Mar 31, 2009	1,224	–	Form 10-Q (filed 2010-05-07) ↗
Q4 2008	Dec 31, 2008	2,126	–	Form 10-K (filed 2011-02-28) ↗
Q3 2008	Sep 30, 2008	893	–	Form 10-Q (filed 2009-10-29) ↗
Q2 2008	Jun 30, 2008	906	–	Form 10-Q (filed 2009-07-24) ↗

Cite this data

StockData. (2026). Merck Research and Development (R&D) ($M) ($M), quarterly Q2 2008–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_inc_rd

See every metric in the Merck KPI table. Data updated Oct 26, 2026.